Skip to main content
. 2023 Jul 12;14:1188969. doi: 10.3389/fendo.2023.1188969

Figure 2.

Figure 2

(A) Mean difference of BMD in the lumbar spine at 3 months from baseline between denosumab and romosozumab. (B) Mean difference of BMD in the femoral neck at 3 months from baseline between denosumab and romosozumab. (C) Mean difference of BMD in the total hip at 3 months from baseline between denosumab and romosozumab. (D) Mean difference of P1NP at 3 months from baseline between denosumab and romosozumab. (E) Mean difference of TRACP-5b at 3 months from baseline between denosumab and romosozumab. BMD, bone mineral density; DENO, denosumab; ROMO, romosozumab.